Atlas Trials

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

Clinical trial NCT00241670 · COMPLETED

Trial details

NCT number
NCT00241670
Sponsor
medac GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Brain CancerBrain TumorsCancer of BrainPrimary Brain TumorsBrain Tumor, Primary
Start date
1999-10-01
Primary completion
2004-07-01
Enrollment
415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.